PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93025C00007SBIR BASE YEAR - TOPIC 130 — Adjuvax LLC

Adjuvax LLC holds $3.0M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 4 offers. Set-aside status: SBA. Recompete timing centers on the Oct 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Niaid

Awarding office

Adjuvax LLC

Recipient

Oct 31, 2027

PoP end

$3M

Obligated

$3M

Potential

541714

NAICS

AN12

PSC

SBA

Set-aside

4 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Adjuvax LLC — $90

Contract facts

SBA

Contract number75N93025C00007

AgencyNational Institutes Of Health Niaid

Awarding officeNational Institutes Of Health Niaid

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentAdjuvax LLC

CAGE8RK88

UEIEGVNJG3GMEL7

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN12

Place of performanceBIRMINGHAM AL

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

Related solicitationPHS20241

PoP startNov 1, 2024

PoP end (current)Oct 31, 2027

Obligated$3M

Current value$3M

Potential value$3M

SBIR BASE YEAR - TOPIC 130 ADJUVANT DISCOVERY AND DOWN-SELECTION FOR VACCINES AGAINST INFECTIOUS AND IMMUNE-MEDIATED DISEASES is a federal SBA award for National Institutes Of Health Niaid held by Adjuvax LLC. Estimated value $3M ($3M obligated). Current period of performance ends Oct 31, 2027. Last award drew 4 bidders. Place of performance: BIRMINGHAM AL. Related solicitation PHS20241.

SBIR BASE YEAR - TOPIC 130 ADJUVANT DISCOVERY AND DOWN-SELECTION FOR VACCINES AGAINST INFECTIOUS AND IMMUNE-MEDIATED DISEASES

Recompete timing

Public

● Expiring in 419 days

Current PoP ends Oct 31, 2027 (419 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Adjuvax LLC — $3.0M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$3.0M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N93025C00007?

75N93025C00007 (SBIR BASE YEAR - TOPIC 130) is a National Institutes Of Health Niaid award with a potential value of $3M, currently held by Adjuvax LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93025C00007?

National Institutes Of Health Niaid awarded 75N93025C00007 to Adjuvax LLC (potential $3M).

Who is the incumbent on 75N93025C00007?

Adjuvax LLC is the incumbent with $3.0M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Oct 31, 2027.

When does Adjuvax LLC’s 75N93025C00007 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N93025C00007 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Apr 15, 2025